Innovation in Switzerland’s pharmaceutical industry has fallen for the second year in a row, a new study shows, underscoring how it is trailing foreign competitors in digital research and clinical trials.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.